GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Coloplast A/S (MEX:0QBO) » Definitions » E10

Coloplast A/S (MEX:0QBO) E10 : MXN44.58 (As of Mar. 2024)


View and export this data going back to 2015. Start your Free Trial

What is Coloplast A/S E10?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Coloplast A/S's adjusted earnings per share data for the three months ended in Mar. 2024 was MXN13.476. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is MXN44.58 for the trailing ten years ended in Mar. 2024.

During the past 12 months, Coloplast A/S's average E10 Growth Rate was 6.50% per year. During the past 3 years, the average E10 Growth Rate was 11.20% per year. During the past 5 years, the average E10 Growth Rate was 11.90% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

During the past 13 years, the highest 3-Year average E10 Growth Rate of Coloplast A/S was 13.30% per year. The lowest was 8.20% per year. And the median was 11.55% per year.

As of today (2024-06-22), Coloplast A/S's current stock price is MXN2082.59. Coloplast A/S's E10 for the quarter that ended in Mar. 2024 was MXN44.58. Coloplast A/S's Shiller PE Ratio of today is 46.72.

During the past 13 years, the highest Shiller PE Ratio of Coloplast A/S was 84.59. The lowest was 36.47. And the median was 58.86.


Coloplast A/S E10 Historical Data

The historical data trend for Coloplast A/S's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Coloplast A/S E10 Chart

Coloplast A/S Annual Data
Trend Sep14 Sep15 Sep16 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only 35.85 54.14 50.12 54.79 53.26

Coloplast A/S Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 43.30 45.94 53.26 51.55 44.58

Competitive Comparison of Coloplast A/S's E10

For the Medical Instruments & Supplies subindustry, Coloplast A/S's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Coloplast A/S's Shiller PE Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Coloplast A/S's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Coloplast A/S's Shiller PE Ratio falls into.



Coloplast A/S E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Coloplast A/S's adjusted earnings per share data for the three months ended in Mar. 2024 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=13.476/118.4000*118.4000
=13.476

Current CPI (Mar. 2024) = 118.4000.

Coloplast A/S Quarterly Data

per share eps CPI Adj_EPS
201406 8.723 99.700 10.359
201409 9.183 99.700 10.905
201412 9.141 99.400 10.888
201503 8.446 100.200 9.980
201506 7.838 100.300 9.252
201509 -16.988 100.200 -20.074
201512 9.710 99.800 11.520
201603 11.076 100.200 13.088
201606 12.849 100.600 15.122
201609 5.825 100.200 6.883
201612 13.038 100.300 15.391
201703 11.857 101.200 13.872
201706 11.713 101.200 13.704
201709 13.773 101.800 16.019
201712 13.804 101.300 16.134
201803 12.993 101.700 15.127
201806 13.770 102.300 15.937
201809 14.306 102.400 16.541
201812 13.953 102.100 16.181
201903 14.036 102.900 16.150
201906 14.583 102.900 16.780
201909 10.834 102.900 12.466
201912 14.363 102.900 16.527
202003 17.331 103.300 19.864
202006 16.279 103.200 18.677
202009 17.071 103.500 19.529
202012 17.337 103.400 19.852
202103 17.339 104.300 19.683
202106 18.962 105.000 21.382
202109 19.909 105.800 22.280
202112 17.643 106.600 19.596
202203 13.564 109.900 14.613
202206 17.316 113.600 18.048
202209 15.494 116.400 15.760
202212 14.741 115.900 15.059
202303 14.104 117.300 14.236
202306 14.919 116.400 15.175
202309 13.636 117.400 13.752
202312 13.386 116.700 13.581
202403 13.476 118.400 13.476

Add all the adjusted EPS together and divide 10 will get our e10.


Coloplast A/S  (MEX:0QBO) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Coloplast A/S's Shiller P/E Ratio of today is calculated as

Shiller PE Ratio=Share Price/E10
=2082.59/44.58
=46.72

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Shiller P/E Ratio of Coloplast A/S was 84.59. The lowest was 36.47. And the median was 58.86.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Coloplast A/S E10 Related Terms

Thank you for viewing the detailed overview of Coloplast A/S's E10 provided by GuruFocus.com. Please click on the following links to see related term pages.


Coloplast A/S (MEX:0QBO) Business Description

Address
Holtedam 1-3, Humlebaek, DNK, DK-3050
Coloplast is a leading global competitor in ostomy management and continence care. The firm designs, manufactures, and markets ostomy care systems, disposable containment devices, paste, powder, seals, and intermittent catheters for continence care. Coloplast also maintains a tertiary presence in the urology and woundcare markets, where it manufactures and markets penile implants, slings for incontinence and prolapse, and wound dressings. The company derives more than 60% of sales from Europe, 24% from other developed countries, and 17% from the rest of the world.

Coloplast A/S (MEX:0QBO) Headlines

No Headlines